Toxicological Sciences 61, 54-61 (2001)
Copyright © 2001 by the Society of Toxicology
BIOTRANSFORMATION AND TOXICOKINETICS |
Comparative Xenobiotic Metabolism between Tg.AC and p53+/– Genetically Altered Mice and Their Respective Wild Types
Laboratory of Pharmacology and Chemistry, National Toxicology Program, National Institute of Environmental Health Sciences, MD C3-02, P.O. Box 12233, Research Triangle Park, North Carolina 27709–2233
The use of transgenic animals, such as v-Ha-ras activated (Tg.AC) and p53+/– mice, offers great promise for a rapid and more sensitive assay for chemical carcinogenicity. Some carcinogens are metabolically activated; therefore, it is critical that the altered genome of either of these model systems does not compromise their capability and capacity for metabolism of xenobiotics. The present work tests the generally held assumption that xenobiotic metabolism in the Tg.AC and p53+/– mouse is not inherently different from that of the respective wild type, the FVB/N and C57BL/6 mouse, by comparing each genotype's ability to metabolize benzene, ethoxyquin, or methacrylonitrile. Use of these representative substrates offers the opportunity to examine arene oxide formation, aromatic ring opening, hydroxylation, epoxidation, O-deethylation, and a number of conjugation reactions. Mice were treated by gavage with 14C-labeled parent compound, excreta were collected, and elimination routes and rates, as well as 14C-derived metabolite profiles in urine, were compared between relevant treatment groups. Results of this study indicated that metabolism of the 3 parent compounds was not appreciably altered between either FVB/N and Tg.AC mice or C57BL/6 and p53+/– mice. Further, expression of CYP1A2, CYP2E1, CYP3A, and GST-
in liver of naive genetically altered mice was similar to that of corresponding wild-type mice. Thus, these results suggest that the inherent ability of Tg.AC and p53+/– mice to metabolize xenobiotics is not compromised by their altered genomes and would not be a factor in data interpretation of toxicity studies using either transgenic mouse line.
Key Words: transgenic mouse; Tg.AC mouse; p53+/mouse; metabolism; cytochrome P450; GST-; ethoxyquin; benzene; methacrylonitrile.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Izzotti, C. Cartiglia, M. Longobardi, M. Bagnasco, A. Merello, M. You, R. A. Lubet, and S. De Flora Gene Expression in the Lung of p53 Mutant Mice Exposed to Cigarette Smoke Cancer Res., December 1, 2004; 64(23): 8566 - 8572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Martin, M. P. Jokinen, H. P. Honeycutt, A. Quinn, F. W. Kari, J. C. Barrett, and J. E. French Tumor Spectrum in the p53 Heterozygous Zeta Globin-Promoted Tg.AC (v-Ha-ras) Bitransgenic Mouse Model Toxicol Pathol, June 1, 2004; 32(4): 418 - 425. [Abstract] [PDF]
|
|
|
|
 |
|
 S. E. Boley, V. A. Wong, J. E. French, and L. Recio p53 Heterozygosity Alters the mRNA Expression of p53 Target Genes in the Bone Marrow in Response to Inhaled Benzene Toxicol. Sci., April 1, 2002; 66(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|